MedEngine Oy announced today that Saku Torvinen, PhD, joins MedEngine Oy as Director of Market Access. At MedEngine, he will be responsible for the launch…
MedEngine Oy announced today that it has acquired the Institute of Applied Economics and Health Research ApS (ApHER), a leading Danish medical data science company.…
Vedolizumab may have a corticosteroid sparing effect in real-world clinical practice, a new Finnish study reveals. The incidence of inflammatory bowel disease (IBD), which include ulcerative colitis…
MedEngine Oy, a company specialized in high-quality medical data science services, and BC Platforms AG, a world leader in genomic data management and analytics, today…
Finland is in a good position to begin building a globally competitive ecosystem for real-world data (RWD) research, a qualitative survey conducted by MedEngine reveals.…
Suomalaiset lääkealan asiantuntijapalveluihin erikoistuneet DRA Consulting Oy ja MedEngine Oy ovat aloittaneet Pohjoismaat kattavan yhteistyön. Yritysten keskeisenä tavoitteena on kehittää entistä tehokkaampia Market Access -palveluita…
MedEngine, a premium service provider for pharmaceutical and health technology industries, reports a strong financial result in 2017. The company’s revenue grew 61% to 1.6…
Over the past 10 years, medical affairs has lifted its profile probably more than any other function in the pharmaceutical industry. Currently, medical affairs is…
The 20th Annual European Congress of The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) was held in Glasgow, Scotland on Nov 4–8th 2017. The event attracted…
The current trend towards a data-driven world is affecting everyone—including the pharmaceutical industry. As the volume and complexity of medical data grows and analytics methods continue developing,…